Financhill
Back

Structure Therapeutics Quote, Financials, Valuation and Earnings

Structure Therapeutics Price Quote

$30.10
-2.61 (-7.98%)
(Updated: November 21, 2024 at 5:55 PM ET)

Structure Therapeutics Key Stats

Sell
26
Structure Therapeutics (GPCR) is a Sell

Day range:
$32.04 - $33.18
52-week range:
$26.61 - $66.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.03%

Volume:
489.3K
Avg. volume:
754.5K
1-year change:
-38.81%
Market cap:
$1.8B
Revenue:
$0
EPS:
$-2.19

How Much Does Structure Therapeutics Make?

Data Unavailable

Is Structure Therapeutics Growing As A Company?

Data Unavailable

Structure Therapeutics Stock Price Performance

What Is Structure Therapeutics 52-Week High & Low?

Structure Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Structure Therapeutics?

Is Structure Therapeutics Cash Flow Positive?

  • What Is GPCR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$101.9M
  • What Is Structure Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $796.3M
  • What Is Structure Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$572.9M

Structure Therapeutics Return On Invested Capital

Data Unavailable

Structure Therapeutics Earnings Date & Stock Price

Structure Therapeutics Competitors

Structure Therapeutics Dividend Yield

Structure Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.14%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 85.82
Upside from Last Price: 162.36%

Major Shareholders

  • How many GPCR shares are owned by institutional investors?
    131.2M GPCR shares are owned by institutional investors
  • How many GPCR shares are owned by insiders?
    2.2M GPCR shares are owned by insiders